Augmont IPO signals nearly 50% listing gain on Day 2: Should you subscribe?

Augmont Enterprises IPO enters the second day of bidding on Monday, with the grey market signalling a potential listing gain of nearly 50%.As of 1:07 PM, the IPO's latest grey market premium, or GMP, stands at Rs 390 against the upper price band of Rs 788. This indicates an estimated listing price of around Rs 1,178 if the current premium holds for the IPO.The Rs 825 crore IPO opened for subscription on August 21 and will close bidding on August 25. The price band for the IPO has been fixed at Rs 750-788 per share, while the lot size is 19 shares.At the upper price band, a retail investor would need Rs 14,972 to apply for one lot. The issue comprises a fresh issue of Rs 620 crore and an offer for sale of Rs 205 crore. The shares are proposed to be listed on the NSE and BSE on August 31. Importantly, the nearly 50% figure is the GMP-implied potential listing gain and not an actual market return, as the shares have not yet listed.WHAT DOES AUGMONT IPO GMP SIGNAL?The latest GMP for Augmont Enterprises IPO is Rs 390. Adding this to the upper IPO price of Rs 788 gives an estimated listing price of Rs 1,178. This implies a potential gain of around 49.5% over the IPO price.The GMP has strengthened sharply during the IPO period. It was around Rs 300 when the issue opened, indicating a potential listing gain of around 38%. It has since moved higher, signalling stronger expectations in the unofficial market.However, GMP is not an official price indicator and can change before the actual listing. The eventual listing price could therefore be different from the GMP-implied level.SHOULD YOU SUBSCRIBE FOR AUGMONT IPO?At Rs 390, the current GMP indicates an estimated listing price of Rs 1,178 against the IPO's upper price of Rs 788. That translates into a potential gain of around 49.5%. But it is important for investors not to treat the GMP as a guaranteed return.Anand Rathi, founder and chairman of the Anand Rathi Group, has recommended subscribing to the IPO for medium to long-term investors, reported Moneycontrol.At the upper price band of Rs 788, the brokerage values Augmont at around 19.5 times FY26 earnings and 7.1 times book value, as per a report by Deven Choksey Research. This highlights the company's gold ecosystem, growing consumer base, proprietary price discovery engine and debt-free balance sheet as key positives.For investors looking purely for a listing gain, the current GMP is encouraging and the strong Day 1 subscription adds to the positive sentiment. But the nearly 50% GMP-implied gain does not guarantee that the stock will actually list at Rs 1,178.Meanwhile, those looking at the business over the longer term, raise key questions of whether Augmont can sustain its rapid growth, manage its working-capital requirements, diversify its revenue base and maintain profitability as it scales its gold and silver platform.For now, the GMP points to a potentially strong listing, while the Day 1 subscription and brokerage commentary provide additional support. But investors should look beyond the nearly 50% GMP-implied gain before deciding whether to bid.The IPO was subscribed 2.88 times on the first day of bidding, according to NSE data.The non-institutional investor category led the demand with 4.18 times subscription, while the retail portion was subscribed 2.94 times by the end of Day 1. The strong opening response came alongside the rise in GMP, giving investors positive demand signals as the IPO moved through its second day of bidding.Hence, institutional participation will remain an important factor to watch as the issue moves towards its August 25 closing date.(Disclaimer: The views, opinions, recommendations, and suggestions expressed by experts/brokerages in this article are their own and do not reflect the views of the India Today Group. It is advisable to consult a qualified broker or financial advisor before making any actual investment or trading choices.)- EndsPublished By: Radhika VermaPublished On: Aug 24, 2026 13:59 IST